FDA-Drug2021-05-26Class II
Methylprednisolone Acetate Injectable Suspension USP, 40 mg/mL, 10 mL Multiple Dose Vial, Rx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454 NDC 0703-0045-01
Teva Pharmaceuticals USA
Hazard
Lack of Assurance of Sterility
Sold states
Product was distributed nationwide.
Affected count
7,564/1 multiple dose vial per carton
Manufactured in
400 Interpace Pkwy, N/A, Parsippany, NJ, United States
Products
Methylprednisolone Acetate Injectable Suspension USP, 40 mg/mL, 10 mL Multiple Dose Vial, Rx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454 NDC 0703-0045-01
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0376-2021Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief